市場調査レポート

商品コード

1630617

ロングリードシーケンスの市場規模、シェア、成長分析：提供製品別、技術別、ワークフロー別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Long Read Sequencing Market Size, Share, Growth Analysis, By Offerings, By Technology, By Workflow, By Application, By Usage, By End Users, By Region - Industry Forecast 2025-2032

出版日: 2025年01月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ロングリードシーケンスの世界市場規模は2023年に5億9,581万米ドルと評価され、2024年の7億7,992万米ドルから2032年には67億2,302万米ドルに拡大し、予測期間（2025年～2032年）のCAGRは30.9%で成長する見通しです。

遺伝子シーケンシング市場は、遺伝性疾患の発生率の増加、個別化医療の台頭、第3世代シーケンシングのような技術の進歩によって牽引されています。COVID-19のパンデミックは、診断や医薬品開発における革新的なシーケンス手法の需要をさらに加速させています。単一分子リアルタイム（SMRT）やナノポア（Nanopore）などのロングリードシーケンス技術は、複雑なゲノム領域を正確に解析し、従来の方法では見逃されがちな大規模な構造異常を検出できるため、人気を集めています。これらの利点により、特に遺伝性疾患について、より効率的な診断が可能になります。さらに、医薬品開発やコンパニオン診断のための先進ゲノム技術開発を目的とした提携に見られるように、大手企業による投資の増加が市場の成長を促進すると予想されます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022～2024年）

主要企業プロファイル

Pacific Biosciences of California, Inc.（PacBio）（United States）
Oxford Nanopore Technologies plc（United Kingdom）
Illumina, Inc.（United States）
BGI Genomics Co., Ltd.（China）
10x Genomics, Inc.（United States）
Agilent Technologies, Inc.（United States）
Thermo Fisher Scientific Inc.（United States）
QIAGEN N.V.（Germany）
Takara Bio Inc.（Japan）
Danaher Corporation（United States）
Novogene Co., Ltd.（China）
New England Biolabs, Inc.（United States）
Element Biosciences, Inc.（United States）
Revvity, Inc.（United States）
Eurofins Scientific SE（Luxembourg）
Bio-Rad Laboratories, Inc.（United States）
PerkinElmer, Inc.（United States）
Roche Holding AG（Switzerland）
Merck KGaA（Germany）
Bio-Techne Corporation（United States）

結論と推奨事項

Product Code: SQMIG35H2219

Global Long Read Sequencing Market size was valued at USD 595.81 million in 2023 and is poised to grow from USD 779.92 million in 2024 to USD 6723.02 million by 2032, growing at a CAGR of 30.9% during the forecast period (2025-2032).

The market for genetic sequencing is being driven by the increasing incidence of genetic disorders, the rise of personalized medicine, and advancements in technologies like third-generation sequencing. The COVID-19 pandemic has further accelerated the demand for innovative sequencing methods in diagnostics and drug development. Long read sequencing techniques, such as Single Molecule Real Time (SMRT) and Nanopore, are gaining traction due to their ability to accurately analyze complex genomic regions and detect large structural abnormalities that traditional methods often miss. These advantages allow for more efficient diagnostics, particularly for genetic disorders. Additionally, increased investments from major companies are expected to propel market growth, as seen in partnerships aimed at developing advanced genomic technologies for drug development and companion diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Long Read Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Long Read Sequencing Market Segmental Analysis

Global Long Read Sequencing Market is segmented by Offerings, Technology, Workflow, Application, Usage, End Users and region. Based on Offerings, the market is segmented into Consumables, Instruments and Services. Based on Technology, the market is segmented into Nanopore sequencing, Single-molecule real-time sequencing and Synthetic long-read sequencing. Based on Workflow, the market is segmented into Sequencing, Sample Preparation and Data analysis. Based on Application, the market is segmented into Whole Genome Sequencing, Targeted Sequencing, Metagenomics, Epigenetics, Whole exome sequencing and Other applications. Based on Usage, the market is segmented into Research and Clinical. Based on End Users, the market is segmented into Academic & Research Institutes, Hospitals, Clinics & Diagnostic Labs, Pharmaceutical & Biotechnology Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Long Read Sequencing Market

The Global Long Read Sequencing market is significantly propelled by the growing adoption of next-generation sequencing (NGS) technologies across diverse research domains such as genomics, transcriptomics, and epigenomics. These advanced sequencing methods enable researchers to obtain deeper insights into critical areas like genome assembly, gene expression, and DNA modification patterns. By enhancing the accuracy and completeness of genomic data, long read sequencing becomes an essential tool in NGS-based studies, further driving its implementation in various scientific investigations. This increasing demand for comprehensive genomic analysis fosters the overall growth of the long read sequencing market on a global scale.

Restraints in the Global Long Read Sequencing Market

The global Long Read Sequencing market faces several restraints, notably the high expenses associated with these advanced technologies. Compared to conventional short read sequencing, long read sequencing incurs greater costs related to equipment, reagents, and data analysis. This financial burden can restrict the implementation of long read sequencing methods, particularly in clinical diagnostics and resource-limited research environments, where budget constraints may hinder the widespread adoption of these innovative yet expensive sequencing options. Consequently, the elevated costs present a significant challenge for the growth and accessibility of long read sequencing in various sectors.

Market Trends of the Global Long Read Sequencing Market

The Global Long Read Sequencing market is witnessing robust growth as healthcare and research institutions increasingly adopt these advanced technologies for their superior ability to deliver comprehensive genomic insights. This shift is primarily fueled by the need for accurate genome assembly, structural variant analysis, and complex transcriptomic studies, which short read sequencing often struggles to address. Moreover, the expanding applications in personalized medicine, oncology, and genetic research are amplifying market demand, while technological advancements and reduced costs further enhance accessibility. As a result, long read sequencing is positioning itself as a pivotal tool in the genomics landscape, shaping the future of precision medicine and genetic research.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape

Global Long Read Sequencing Market Size by Offerings & CAGR (2025-2032)

Market Overview
Consumables
Instruments
Services

Global Long Read Sequencing Market Size by Technology & CAGR (2025-2032)

Market Overview
Nanopore sequencing
Single-molecule real-time sequencing
Synthetic long-read sequencing

Global Long Read Sequencing Market Size by Workflow & CAGR (2025-2032)

Market Overview
Sequencing
Sample Preparation
Data analysis

Global Long Read Sequencing Market Size by Application & CAGR (2025-2032)

Market Overview
Whole Genome Sequencing
Targeted Sequencing
Metagenomics
Epigenetics
Whole exome sequencing
Other applications

Global Long Read Sequencing Market Size by Usage & CAGR (2025-2032)

Market Overview
Research
Clinical

Global Long Read Sequencing Market Size by End Users & CAGR (2025-2032)

Market Overview
Academic & Research Institutes
Hospitals, Clinics & Diagnostic Labs
Pharmaceutical & Biotechnology Companies
Other End Users

Global Long Read Sequencing Market Size & CAGR (2025-2032)

North America (Offerings, Technology, Workflow, Application, Usage, End Users)
- US
- Canada
Europe (Offerings, Technology, Workflow, Application, Usage, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Offerings, Technology, Workflow, Application, Usage, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Offerings, Technology, Workflow, Application, Usage, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Offerings, Technology, Workflow, Application, Usage, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Pacific Biosciences of California, Inc. (PacBio) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
10x Genomics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novogene Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Element Biosciences, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ロングリードシーケンスの市場規模、シェア、成長分析：提供製品別、技術別、ワークフロー別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Long Read Sequencing Market Size, Share, Growth Analysis, By Offerings, By Technology, By Workflow, By Application, By Usage, By End Users, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

ロングリードシーケンス市場規模：提供製品別

ロングリードシーケンス市場規模：技術別

ロングリードシーケンス市場規模：ワークフロー別

ロングリードシーケンス市場規模：用途別

ロングリードシーケンス市場規模：利用別

ロングリードシーケンス市場規模：エンドユーザー別

ロングリードシーケンス市場規模